Book Value per Share: Wave Life Sciences Ltd (WVE)

Wave Life Sciences Ltd. (WVE) - corporate logo

Serving as a valuation tool, the Wave Life Sciences (WVE) price chart on the GURU.Markets platform, where the indicator stands at 2.35, reflects the dynamics of a business creating sterile drugs via the PRISM AI system and partnerships with Takeda and GSK. Wave Life Sciences (WVE) specializes in treating rare pathologies, which creates opportunities for premium pricing power. The implementation of automated laboratories for 24/7 chain synthesis significantly reduces preclinical research timelines.

Wave Life Sciences Ltd (WVE) Equity per Share: for the period 07/04/2022 - 10/27/2026

Summary analytical data breakdowns for wavelifesciences.com (WVE)

- price and consensus price forecast:
Stock Price Wave Life Sciences Corp|WVE - Average Forecast Price
- market capitalization data:
Market Capitalization Wave Life Sciences Ltd.|WVE - Business Value
- book capitalization data:
Net Assets per Single Share Wave Life Sciences|WVE - Accounting Capitalization|Market Capitalization to Book Value Ratio wavelifesciences.com|WVE - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio Wave Life Sciences|WVE - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Wave Life Sciences Ltd.|WVE - Company Aggregate Debts|Debt to Book Value Wave Life Sciences Ltd.
Initial company analysis:WVE - Wave Life Sciences Corp
Flagship merchandise of wavelifesciences.com

Book value per share reflects the company's equity minus liabilities, determining the fundamental strength of its capital. For Wave Life Sciences (WVE), this metric demonstrates the resource base available for scaling its RNA platform into a pipeline of accessible drugs. By analyzing this book value per share chart, an investor assesses the level of asset coverage for risks. Growth in this metric confirms financial stability, while stagnation signals a risk of opportunity cost in the absence of operational growth.

Competitors of Wave Life Sciences (WVE)

TEM (Tempus AI, Inc.) - Book Value per Share|QGEN - Net Asset Value per Share|Book Value per Share Ionis Pharmaceuticals|RGEN (repligen.com) - Equity per Share|Net Assets per Single Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRISPR Therapeutics Inc|Book Value per Share WGS|Book Value per Share Ultragenyx Corp RARE|Beam Therapeutics Inc. - Accounting Value per Share|Accounting Value per Share sarepta.com SRPT|Twist Bioscience, Inc. - Book Value per Share|10x Genomics Inc (TXG) - Book Value per Share|Intellia (NTLA) - Accounting Value per Share|Stoke Corp (STOK) - Net Assets per Single Share|Book Value per Share BLFS (BioLife Solutions, Inc.)|Net Asset Value per Share mazetx.com (MAZE)|Sionna Therapeutics (SION) - Accounting Value per Share|Accounting Value of a Share PRME (Prime Medicine Inc)|Net Assets per Single Share Taysha TSHA|Net Assets per Single Share uniQure Pharma QURE|Book Value per Share MGTX (MeiraGTx Holdings plc)|RGNX - Net Assets per Share|Book Value per Share Solid Biosciences (SLDB)|Ocugen Inc (OCGN) - Share Book Value|Book Value per Share PACB (Pacific Biosciences of California)|Net Asset Value per Share Benitec Corp (BNTC)|Design Therapeutics (DSGN) - Accounting Value per Share|Accounting Value of a Share RCKT (rocketpharma.com)|Net Assets per Single Share FDMT|Net Assets per Share Lexeo Therapeutics Inc. LXEO|KRRO: Book Value per Share|EDIT - Accounting Value per Share|Silence Therapeutics - Book Value per Share|ProQR Therapeutics (PRQR) - Net Assets per Share|Book Value per Share CDXS (Codexis Inc)|Net Asset Value per Share SGMO|Net Assets per Single Share Nautilus Biotechnology NAUT|Equity per Share Metagenomi Therapeutics (MGX)|Precision BioSciences, Inc. - Book Value per Share|Accounting Value per Share Generation Bio Co GBIO|BOLD (Boundless Bio) - Book Value per Share|XCUR: Net Asset Value per Share|imunon.com - Net Assets per Single Share|Net Assets per Share Phio Pharmaceuticals Corp.|Accounting Value per Share MBIO|Accounting Value per Share TransCode (RNAZ)|Accounting Value per Share Bionano Genomics, Inc. (BNGO)|Net Assets per Single Share Applied DNA Sciences Inc (APDN)|BLUE: Book Value per Share|Net Asset Value per Share ImmunoPrecise Antibodies Ltd IPA|Omega Therapeutics (OMGA) - Book Value per Share|OMIC: Equity per Share|Net Assets per Single Share Regulus Therapeutics Inc.|Syros Pharmaceuticals Inc. (SYRS) - Equity per Share|TBIO (Codex DNA) - Book Value per Share|Book Value per Share TRACON Pharmaceuticals, Inc (TCON)|Accounting Value per Share UBX (Unity Biotechnology)